Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Hydroxychloroquine and pregnancy Plaquenil pulmonary toxicity Hydroxychloroquine lightening cream 2 walmart Plaquenil and Breast cancer - from FDA reports Summary Breast cancer is found among people who take Plaquenil, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years, also take medication Enbrel, and have High blood pressure. Objective To assess the efficacy of chloroquine Aralen phosphate and hydroxychloroquine Plaquenil sulfate in the treatment of patients with neurosarcoidosis who either do not respond to corticosteroid therapy or develop unacceptable side effects. Design Retrospective study. Preclinical studies indicate autophagy inhibition with hydroxychloroquine HCQ can augment the efficacy of DNA-damaging therapy. The primary objective of this trial was to determine the maximum tolerated dose MTD and efficacy of HCQ in combination with radiation therapy RT and temozolomide TMZ for newly diagnosed glioblastoma GB. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Plaquenil and radiotherapy What Should Lupus Patients Know About Radiation Treatment., Effectiveness of Chloroquine and Hydroxychloroquine in. Imuran plaquenil together headacheHydroxychloroquine yellow skinAmaurosis fugax from plaquenil Radiation pneumonitis is reported only by a few people who take Plaquenil. We study 48,911 people who have side effects while taking Plaquenil from Food and Drug Administration FDA. Among them, 3 have Radiation pneumonitis. Find out below who they are, when they have Radiation pneumonitis and more. Will you have Radiation pneumonitis with Plaquenil - eHealthMe. A phase I/II trial of hydroxychloroquine in conjunction.. Concurrent versus sequential whole brain radiotherapy and TKI.. Background Hydroxychloroquine sulfate and other antimalarial drugs have been used successfully as adjunctive therapy for patients with cutaneous lesions of dermatomyositis over the past 20 years. An increased incidence of cutaneous reactions to hydroxychloroquine has been postulated to occur. RATIONALE Drugs used in chemotherapy, such as hydroxychloroquine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Introduction. The extent to which patients with pre-existing connective tissue diseases such as rheumatoid arthritis, discoid or systemic lupus erythematosus SLE, polymyositis, dermatomyositis, and scleroderma and mixed connective tissue diseases are at increased risk of radiotherapy toxicity has been controversial.